Ubs Group Ag Coll Plant Biotechnologies LTD Call Options Transaction History
Ubs Group Ag
- $400 Billion
- Q2 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding CLGN
# of Institutions
17Shares Held
1.95MCall Options Held
0Put Options Held
0-
Pinnacle Associates LTD564KShares$2.8 Million0.05% of portfolio
-
Investment Management Of Virginia LLC464KShares$2.31 Million0.63% of portfolio
-
Villere St Denis J & CO LLC390KShares$1.94 Million0.17% of portfolio
-
Roumell Asset Management, LLC Chevy Chase, MD276KShares$1.37 Million2.69% of portfolio
-
Brown Advisory Inc119KShares$593,7410.0% of portfolio
About CollPlant Biotechnologies Ltd
- Ticker CLGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,086,500
- Market Cap $55.1M
- Description
- CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering tech...